ACTRN12624000784516尚未招募Unknown
Evaluating the safety, tolerability and efficacy of the ketogenic diet therapy in adults with chronic migraines
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Aged 18-60 at time of enrolment
- •- At least a 1-year history of migraine, and current diagnosis of chronic migraine for three months (The International Classification of Headache Disorders 3 (ICHD-3 criteria)
- •- No change in migraine treatment in the preceding three months prior to enrolment
排除标准
- •- Body mass index less then 18.5kg/m2
- •- Fatty acid or amino acid oxidation disorder
- •- Pre-existing renal and/or liver failure
- •- Known diagnosis of diabetes mellitus
- •- History of pancreatitis
- •- HbA1c greater then or equal to 6%
- •- Prior history of eating disorder that the treating clinician or dietitian reasonably considers may be exacerbated by dietary therapy
- •- Women who are pregnant, breastfeeding or planning to become pregnant during the study
- •- Allergy to medical adhesives
- •- Unable to participate in study visits.
研究者
相似试验
已完成
4 期
A clinical trial to study the effect of a Under eye Skin cream containing Biophytex LS 8740 and Proteasyl TP LS 8657 in patients with under eye dark circles.CTRI/2010/091/001346Glenmark Pharmaceutical limited500
已完成
4 期
A clinical trial to assess the efficacy, safety and tolerability of tigecycline in adult hospitalized patients with community acquired pneumonia (CAP).CTRI/2010/091/001439Glenmark Pharmaceuticals Limited120
进行中（未招募）
1 期
Phase 2b study evaluating efficacy, safety and tolerability of study drug called NGM282 (Aldafermin) in Patients with Compensated Cirrhosis Due to Nonalcoholic SteatohepatitisCompensated Cirrhosis Due to Nonalcoholic SteatohepatitisMedDRA version: 22.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersMedDRA version: 20.1Level: LLTClassification code 10064844Term: Compensated cirrhosisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2019-002341-38-FRGM Biopharmaceuticals, Inc.150
已完成
不适用
study on low back paiCTRI/2016/10/007348Dr Reddys Laboratories Pvt Ltd
进行中（未招募）
1 期
Phase 2b study evaluating efficacy, safety and tolerability of study drug called NGM282 (Aldafermin) in Patients with Compensated Cirrhosis Due to Nonalcoholic SteatohepatitisEUCTR2019-002341-38-BEGM Biopharmaceuticals, Inc.150